Nektar Therapeutics
NKTR
#5687
Rank
A$1.74 B
Marketcap
A$85.66
Share price
-1.37%
Change (1 day)
261.12%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.45 Billion

According to Nektar Therapeutics 's latest financial reports the company's total assets are A$0.45 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.48 B-16.38%
2023-12-31A$0.58 B-44.05%
2022-12-31A$1.04 B-32.24%
2021-12-31A$1.54 B-23%
2020-12-31A$2.00 B-29.14%
2019-12-31A$2.82 B-7.47%
2018-12-31A$3.05 B368.26%
2017-12-31A$0.65 B-17.41%
2016-12-31A$0.78 B15.3%
2015-12-31A$0.68 B26.85%
2014-12-31A$0.53 B10.77%
2013-12-31A$0.48 B1.7%
2012-12-31A$0.47 B-19.02%
2011-12-31A$0.59 B15.28%
2010-12-31A$0.51 B-19.91%
2009-12-31A$0.64 B-19.36%
2008-12-31A$0.79 B-4.2%
2007-12-31A$0.82 B-14.89%
2006-12-31A$0.97 B-16.95%
2005-12-31A$1.17 B21.89%
2004-12-31A$0.96 B16.01%
2003-12-31A$0.82 B-22.93%
2002-12-31A$1.07 B-17.64%
2001-12-31A$1.30 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
A$135.70 B 29,812.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 69,166.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$195.03 B 42,888.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
A$0.30 B-33.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$172.31 B 37,881.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
A$31.71 B 6,890.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$3.50 B 673.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
A$290.28 B 63,884.71%๐Ÿ‡บ๐Ÿ‡ธ USA